The COVID-19 pandemic has accelerated the shift from brick-and-mortar to online medication, according to Zur Rose CEO Walter Oberhänsli. The Swiss e-commerce pharmacy is focusing on Germany as its core market, where mandatory electronic prescriptions are being discussed for 2022, with France as its second priority.